Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Geen verhoogd risico op andere kanker bij lynchsyndroom
sep 2018 | Gynaecologische oncologie, Maag-darm-leveroncologie